Health and life sciences news releases, as the companies issue them.
All releases
27 recent releases from TMX Newsfile, newest first, refreshed every 5 minutes. This list follows a fixed rule; nothing in it is chosen, ranked or paid for. Times are Eastern.
Defence, a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to invite shareholders to its upcoming Annual General Meeting ("AGM" or the "Meeting") on December 10, 2026, in…
Highlights: Exclusive distribution arrangement in Qatar with an initial 36-month term, intended to support local registration, marketing, sale and distribution of TempraMed productsMinimum unit purchase commitment with…
Friday, November 13, 2026
Noveris Health Sciences Inc.CSE: NVRSFSE: 0NF1OTC Pink: MYCOFTMX Newsfile
Noveris Health Sciences Inc. announces that its board of directors (the "Board") has commenced a strategic review process to evaluate the strategic and financial alternatives available to the Company (the "Strategic…
Delivra Health Brands Inc.TSXV: DHBOTCQB: DHBUFTMX Newsfile
Delivra Health, hereby issues a correction to its news release dated November 11, 2026 (the "Prior Release") regarding a shares for payables settlement agreement to satisfy an aggregate of approximately $90,000 of the…
Vesalius, a leading global peptide and longevity company, today announced the appointment of Harvey Spevak, as Chairman of its Board of Directors, effective November 13, 2026. The appointment follows a US$6.5 million…
Thursday, November 12, 2026
Appili Therapeutics Inc. (NEX: APLI.H)OTC Pink: APLIFTMX Newsfile
Appili Therapeutics Inc. (NEX: APLI.H) (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company building a National Security Healthcare platform focused on dual-use medical technologies, today…
Therma Bright, a developer and investment partner specializing in advanced medical device technologies, announces that further to its news release of October 23, 2026, it has received interest above the previously…
KALA BIO, today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock"), at a ratio of 1 post-split share for every 30 pre-split shares. The reverse…
Charlotte's Web Holdings, Inc.TSX: CWEBOTCQX: CWBHFTMX Newsfile
Charlotte's Web, a botanical wellness innovation company and a market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended September 30, 2026. All amounts are…
Vesalius is pleased to announce that it will commence trading on the Canadian Securities Exchange ("CSE") under the symbol "VLAB" today, November 12, 2026. "Today marks an important milestone for Vesalius Labs, and I…
Kiora today reported financial results for the third quarter ended September 30, 2026, and provided a business update highlighted by the in-licensing of KIO-401, a late-stage, oral neuroprotective calpain inhibitor. The…
Wednesday, November 11, 2026
Delivra Health Brands Inc.TSXV: DHBOTCQB: DHBUFTMX Newsfile
Delivra Health, a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce it has entered into a shares for payables settlement agreement (the "Agreement"), to…
FloraWorks, a cannabinoid biotechnology company, today announced that an independent panel of scientific experts unanimously concluded its proprietary, high-purity cannabinol (CBN) ingredient, TruCBN™, is Generally…
Quinsam is announcing its Q3/2026 results, with net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) versus net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) in Q3/2025.…
Rhelion Life Sciences Corp.CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
Psyched Wellness Ltd. (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products…
Doseology announces revocation of the management cease trade order ("MCTO") previously issued on October 29, 2026; and its intention to voluntarily adopt the Semi-Annual Reporting ("SAR") Pilot Program pursuant to…
Digicann is pleased to announce that, further to its news release dated June 5, 2026, it has entered into a binding share exchange agreement (the "Definitive Agreement") dated October 31, 2026 and signed on November 4…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"),…
Record quarterly revenue of $14.9 million, up 23% from Q2 2026 and 18% year-over-year. Ohio revenue up 37% year-over-year to $10.9 million, led by Fairfield and Company-grown flower. Operating cash flow of $2.4 million…
Neural announces a change to its Board of Directors and provides updates regarding its previously announced transaction with CWE European Holdings Inc. ("CWE").Board of DirectorsThe Company announces that John Durfy has…
Rhelion, an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
Doseology, a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it was unable to file its annual audited financial statements, management's discussion…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company…
Doseology a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that Larry Latowsky has resigned as a director of the Company, effective immediately. About…